Interfollicular CD10 Expression and Follicular PD1 Tumor-infiltrating lymphocytes as biologic risk factors in patients with previously untreated follicular lymphoma receiving rituximab-based biologic therapy: An Alliance correlative science study (CALGB 50901, 50402, 50701, 50803, 50401)
- Citation:
- Blood vol 126 (23) abstr 334
- Meeting Instance:
- ASH 2015
- Year:
- 2015
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Meta-Analysis
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- 3301
- Program:
- TRP
- Primary Committee:
- Correl Sci NOS
- Sec. Committees:
- Pharmas:
- Grants:
- U10CA180821, U10CA180882
- Corr. Author:
- Authors:
- Aliyah R. Sohani Brandy Pitcher Amy Chadburn Jonathan Said Peter Martin Myron S. Czuczman Nancy Bartlett Cara Rosenbaum John P. Leonard Bruce D. Cheson Eric D. Hsi
- Networks:
- CAPITAL, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-MO011, LAPS-NY158, NY018
- Study
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-50401, CALGB-50402, CALGB-50701, CALGB-50803, CALGB-50901
- Phases:
- 2
- Keywords: